Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-04-03 Sale | 2025-04-04 4:23 pm | Vir Biotechnology Inc. | VIR | De Backer Marianne Chief Executive Officer | 79,712 | $5.9494 | $474,239 | 822,623 (Indirect Direct) | View |
| 2025-02-26 Sale | 2025-02-27 12:39 pm | Vir Biotechnology Inc. | VIR | de Verneuil Vanina EVP and General Counsel | 7,373 | $9.1418 | $67,402 | 79,460 (Direct) | View |
| 2025-02-24 Sale | 2025-02-25 3:44 pm | Vir Biotechnology Inc. | VIR | SCANGOS GEORGE A Director | 10,056 | $9.4534 | $95,063 | 3,813,528 (Indirect Direct) | View |
| 2025-02-24 Sale | 2025-02-25 3:43 pm | Vir Biotechnology Inc. | VIR | HANLY ANN M. EVP & Chief Technology Officer | 14,168 | $9.4534 | $133,936 | 117,901 (Direct) | View |
| 2025-02-24 Sale | 2025-02-25 3:37 pm | Vir Biotechnology Inc. | VIR | Sabatini Brent SVP, Chief Accounting Officer | 1,562 | $9.4534 | $14,766 | 86,627 (Direct) | View |
| 2025-02-24 Sale | 2025-02-25 3:36 pm | Vir Biotechnology Inc. | VIR | De Backer Marianne Chief Executive Officer | 16,122 | $9.4534 | $152,408 | 1,382,335 (Indirect Direct) | View |
| 2025-02-24 Sale | 2025-02-25 3:34 pm | Vir Biotechnology Inc. | VIR | de Verneuil Vanina EVP and General Counsel | 5,140 | $9.4534 | $48,590 | 156,833 (Direct) | View |
| 2025-02-18 Sale | 2025-02-19 7:11 pm | Vir Biotechnology Inc. | VIR | SCANGOS GEORGE A Director | 10,964 | $9.8117 | $107,575 | 3,823,584 (Indirect Direct) | View |
| 2025-02-13 Sale | 2025-02-14 6:41 pm | Vir Biotechnology Inc. | VIR | Sabatini Brent SVP, Chief Accounting Officer | 1,562 | $9.1494 | $14,291 | 28,189 (Direct) | View |
| 2025-01-08 Sale | 2025-01-08 8:03 pm | Vir Biotechnology Inc. | VIR | SATO VICKI L Director | 10,960 | $12.52 | $137,219 | 1,312,391 (Direct) | View |
| 2024-12-02 Sale | 2024-12-04 3:35 pm | Vir Biotechnology Inc. | VIR | de Verneuil Vanina EVP and General Counsel | 76 | $8.2201 | $625 | 56,973 (Direct) | View |
| 2024-11-06 Sale | 2024-11-07 7:20 pm | Vir Biotechnology Inc. | VIR | de Verneuil Vanina EVP and General Counsel | 4,397 | $10.11 | $44,454 | 56,973 (Direct) | View |
| 2024-11-01 Sale | 2024-11-05 5:51 pm | Vir Biotechnology Inc. | VIR | de Verneuil Vanina EVP and General Counsel | 3,750 | $8.6219 | $32,332 | 61,370 (Direct) | View |
| 2024-09-09 Sale | 2024-09-10 4:28 pm | Vir Biotechnology Inc. | VIR | Napolitano Janet Director | 12,190 | $7.7959 | $95,032 | 11,616 (Direct) | View |
| 2024-06-11 Sale | 2024-06-12 12:21 pm | Vir Biotechnology Inc. | VIR | Ramasastry Saira Director | 4,000 | $10.95 | $43,789 | 14,619 (Direct) | View |
| 2024-04-03 Sale | 2024-04-04 4:14 pm | Vir Biotechnology Inc. | VIR | De Backer Marianne Chief Executive Officer | 72,995 | $9.4577 | $690,365 | 678,457 (Direct) | View |
| 2024-04-01 Sale | 2024-04-02 8:58 pm | Vir Biotechnology Inc. | VIR | HANLY ANN M. EVP & Chief Technology Officer | 2,711 | $10.05 | $27,251 | 132,081 (Indirect Direct) | View |
| 2024-03-27 Sale | 2024-03-28 12:18 pm | Vir Biotechnology Inc. | VIR | Lee Sung EVP & Chief Financial Officer | 6,008 | $9.8875 | $59,404 | 100,492 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-02-22 Option Award | 2025-02-25 3:41 pm | N/A 2035-02-21 | Vir Biotechnology Inc. | VIR | O'Byrne Jason EVP & Chief Financial Officer | 120,000 | $0 | 195,000 (Direct) | View |
| 2025-02-22 Option Award | 2025-02-25 3:39 pm | N/A 2035-02-21 | Vir Biotechnology Inc. | VIR | Eisner Mark EVP and Chief Medical Officer | 120,000 | $0 | 195,000 (Direct) | View |
| 2025-02-22 Option Award | 2025-02-25 3:37 pm | N/A 2035-02-21 | Vir Biotechnology Inc. | VIR | Sabatini Brent SVP, Chief Accounting Officer | 60,000 | $0 | 86,627 (Direct) | View |
| 2025-02-22 Option Award | 2025-02-25 3:36 pm | N/A 2035-02-21 | Vir Biotechnology Inc. | VIR | De Backer Marianne Chief Executive Officer | 720,000 | $0 | 1,382,335 (Direct) | View |
| 2025-02-22 Option Award | 2025-02-25 3:34 pm | N/A 2035-02-21 | Vir Biotechnology Inc. | VIR | de Verneuil Vanina EVP and General Counsel | 105,000 | $0 | 156,833 (Direct) | View |
| 2024-11-15 Option Award | 2024-11-18 1:36 pm | N/A 2034-11-14 | Vir Biotechnology Inc. | VIR | O'Byrne Jason EVP & Chief Financial Officer | 225,000 | $0 | 225,000 (Direct) | View |
| 2024-10-23 Other | 2024-10-24 4:26 pm | N/A N/A | Vir Biotechnology Inc. | VIR | SCANGOS GEORGE A Director | 598,270 | $0 | 4,477,628 (Direct) | View |
Ownership | 2024-10-03 5:11 pm | N/A N/A | Vir Biotechnology Inc. | VIR | O'Byrne Jason EVP & Chief Financial Officer | 0 | $0 | 0 (Direct) | View |
Ownership | 2024-10-02 12:09 pm | N/A N/A | Vir Biotechnology Inc. | VIR | Sabatini Brent SVP, Chief Accounting Officer | 0 | $0 | 88,439 (Direct) | View |
Ownership | 2024-10-02 12:07 pm | N/A N/A | Vir Biotechnology Inc. | VIR | de Verneuil Vanina EVP and General Counsel | 0 | $0 | 245,120 (Direct) | View |
| 2024-07-15 Option Award | 2024-07-16 4:40 pm | N/A 2034-07-14 | Vir Biotechnology Inc. | VIR | Eisner Mark EVP and Chief Medical Officer | 225,000 | $0 | 225,000 (Direct) | View |
| 2024-06-12 Other | 2024-06-12 4:00 pm | N/A N/A | Vir Biotechnology Inc. | VIR | De Backer Marianne Chief Executive Officer | 53,118 | $0 | 784,693 (Direct) | View |
| 2024-05-30 Option Award | 2024-06-03 12:18 pm | 2025-05-30 2034-05-29 | Vir Biotechnology Inc. | VIR | Sigal Charles Elliott Director | 24,000 | $0 | 49,806 (Direct) | View |
| 2024-05-30 Option Award | 2024-06-03 12:17 pm | 2025-05-30 2034-05-29 | Vir Biotechnology Inc. | VIR | SCANGOS GEORGE A Director | 24,000 | $0 | 3,850,548 (Direct) | View |
| 2024-05-30 Option Award | 2024-06-03 12:16 pm | 2025-05-30 2034-05-29 | Vir Biotechnology Inc. | VIR | SATO VICKI L Director | 24,000 | $0 | 1,339,351 (Direct) | View |
| 2024-05-30 Option Award | 2024-06-03 12:15 pm | 2025-05-30 2034-05-29 | Vir Biotechnology Inc. | VIR | Ramasastry Saira Director | 24,000 | $0 | 34,619 (Direct) | View |
| 2024-05-30 Option Award | 2024-06-03 12:14 pm | 2025-05-30 2034-05-29 | Vir Biotechnology Inc. | VIR | NELSEN ROBERT Director | 24,000 | $0 | 13,550,704 (Direct) | View |
| 2024-05-30 Option Award | 2024-06-03 12:13 pm | 2025-05-30 2034-05-29 | Vir Biotechnology Inc. | VIR | Napolitano Janet Director | 24,000 | $0 | 39,806 (Direct) | View |
| 2024-05-30 Option Award | 2024-06-03 12:08 pm | 2025-05-30 2034-05-29 | Vir Biotechnology Inc. | VIR | MORE ROBERT J Director | 24,000 | $0 | 558,573 (Direct) | View |
| 2024-05-30 Option Award | 2024-06-03 11:59 am | 2025-05-30 2034-05-29 | Vir Biotechnology Inc. | VIR | Hatfield Jeffrey S. Director | 24,000 | $0 | 39,806 (Direct) | View |
Ownership | 2024-06-03 11:57 am | N/A N/A | Vir Biotechnology Inc. | VIR | Eisner Mark EVP and Chief Medical Officer | 0 | $0 | 0 (Direct) | View |
| 2024-05-29 Option Award | 2024-05-31 2:43 pm | N/A 2034-05-28 | Vir Biotechnology Inc. | VIR | Farid Ramy Director | 32,000 | $0 | 48,000 (Direct) | View |
Ownership | 2024-05-31 2:42 pm | N/A N/A | Vir Biotechnology Inc. | VIR | Farid Ramy Director | 0 | $0 | 0 (Direct) | View |
| 2024-05-29 Option Award | 2024-05-31 2:40 pm | N/A 2034-05-28 | Vir Biotechnology Inc. | VIR | BISCHOFBERGER NORBERT W Director | 32,000 | $0 | 48,000 (Direct) | View |
Ownership | 2024-05-31 2:38 pm | N/A N/A | Vir Biotechnology Inc. | VIR | BISCHOFBERGER NORBERT W Director | 0 | $0 | 0 (Direct) | View |